Literature DB >> 6608924

Polymorphonuclear cell motility, ankylosing spondylitis, and HLA B27.

C T Pease, J N Fordham, H L Currey.   

Abstract

Polymorphonuclear leucocyte (PMN) function was studied in 29 subjects with ankylosing spondylitis (AS). Of these, 20 were HLA B27+ve and 9 B27-ve. There were 30 controls and, of these, 15 were B27+ve. Random and directed cell migration was measured by 2 techniques: migration through a micropore filter and migration under an agar film. The chemo-attractant was either case in-activated serum or zymosan-activated serum. By both techniques directed motility was increased in subjects with B27 or with AS when compared to the B27-ve controls. This suggests that the disease AS and the possession of B27 are both associated with increased PMN motility.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608924      PMCID: PMC1001483          DOI: 10.1136/ard.43.2.279

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Diminished mixed lymphocyte reaction in ankylosing spondylitis, relatives, and normal individuals all with HL-A 27.

Authors:  B Nikbin; D A Brewerton; D C James; J R Hobbs
Journal:  Ann Rheum Dis       Date:  1976-02       Impact factor: 19.103

2.  Relation between HLA-B27 and clinical features in patients with yersinia arthritis.

Authors:  O Laitinen; M Leirisalo; G Skylv
Journal:  Arthritis Rheum       Date:  1977-06

3.  Action of nonsteroidal, anti-inflammatory drugs on human and rat peripheral leucocyte migration in vitro.

Authors:  K A Brown; A J Collins
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

4.  Micropore filter assay of human granulocyte locomotion: problems and solutions.

Authors:  E G Maderazo; C L Woronick
Journal:  Clin Immunol Immunopathol       Date:  1978-10

5.  Lymphocyte transformation to bacterial antigens in ankylosing spondylitis.

Authors:  A C Mawle; J R Hobbs; R E Warren; D A Brewerton
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

6.  Neutrophil chemotaxis in ankylosing spondylitis, Reiter's disease, and polymyalgia rheumatica.

Authors:  A G Mowat
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

7.  A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

8.  Immune function in ankylosing spondylitics and their relatives: influence of disease and HLA B27.

Authors:  F T Christiansen; B R Hawkins; R L Dawkins
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

9.  Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro.

Authors:  M Leirisalo; H Repo; A Tiilikainen; T U Kosunen; O Laitinen
Journal:  Arthritis Rheum       Date:  1980-09

10.  Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis.

Authors:  M A Khan; I Kushner; W E Braun
Journal:  Arthritis Rheum       Date:  1977-05
View more
  11 in total

1.  The phagocyte oxidative metabolism function in ankylosing spondylitis.

Authors:  D Wendling; J M Didier; D A Vuitton
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

2.  Chemotaxis and chemiluminescence responses of synovial fluid polymorphonuclear leucocytes during acute reactive arthritis.

Authors:  M Leirisalo-Repo; A Lauhio; H Repo
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

Review 3.  Clinical, bacteriological, and serological aspects of Klebsiella infections and their spondylarthropathic sequelae.

Authors:  H Sahly; R Podschun
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

4.  Polymorphonuclear leucocyte motility in men with ankylosing spondylitis.

Authors:  C T Pease; M Fennell; D A Brewerton
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

5.  Normal production of neutrophil activating peptide 1/interleukin 8 in monocytes from subjects with previous yersinia triggered reactive arthritis.

Authors:  H Repo; M Ristola; M Leirisalo-Repo; A Walz; M Baggiolini
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

6.  Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease.

Authors:  P Koivuranta-Vaara; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

7.  Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.

Authors:  H Repo; P Koivuranta-Vaara; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

8.  Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.

Authors:  H Repo; M Jäättelä; M Leirisalo-Repo; M Hurme
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

9.  Raised circulating levels of the eosinophil cationic protein in ankylosing spondylitis: relation with the inflammatory activity and the influence of sulphasalazine treatment.

Authors:  N Feltelius; R Hällgren; P Venge
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

10.  Circulating inhibitor bound elastase in patients with ankylosing spondylitis and rheumatoid arthritis and the influence of sulphasalazine treatment.

Authors:  N Feltelius; R Hällgren
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.